Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Journal of Clinical Psychopharmacology|November 25, 2010
Association between the 1291-C/G polymorphism in the adrenergic α-2a receptor and the metabolic syndromeArne J Risselada, Jelle Vehof, Richard Bruggeman, et al.Bioanalysis|December 11, 2012
Conference Report: the 3rd EBF Focus Meeting: 'Hatching'--emerging technologies approaching the regulated bioanalysis laboratory. Brussels, Belgium, 12-13 June 2012Jessica Dijksman, Neil Henderson, Benno Ingelse, et al.Journal of Clinical Psychopharmacology|January 15, 2009
HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication studyHans Mulder, Dan Cohen, Hans Scheffer, et al.Age and Ageing|December 16, 2016
Cross-national comparison of medication use in Australian and Dutch nursing homesKatja Taxis, Sjoerd Kochen, Hans Wouters, et al.Journal of Clinical Psychopharmacology|July 17, 2007
The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophreniaHans Mulder, Barbara Franke, Annemarie Aart van der-Beek van der, et al.Journal of Clinical Psychopharmacology|January 15, 2009
Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medicationJochem G Gregoor, Jan van der Weide, Hans Mulder, et al.Journal of Clinical Psychopharmacology|November 25, 2010
Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medicationJochem G Gregoor, Hans Mulder, Dan Cohen, et al.Psychiatric Services (Washington, D.C.)|December 12, 2018
Metabolic Syndrome at an Outpatient Clinic for Bipolar Disorders: A Case for Systematic Somatic MonitoringMirjam Simoons, Hans Mulder, Bennard Doornbos, et al.BMC Health Services Research|February 16, 2019
Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocolMirjam Simoons, Henricus G Ruhé, Eric N van Roon, et al.Nederlands Tijdschrift Voor Geneeskunde|December 2, 2021
[Anxiety and mood disorders are independent risk factors for cardiovascular diseases]Davy M C Quadackers, Danielle C Cath, Edith J Liemburg, et al.Pageof 5